Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan
TB-500 is derived from thymosin beta-4, a naturally occurring peptide involved in actin cytoskeleton regulation and cellular movement, which makes it useful in studies examining cytoskeletal organization and cell motility
Lephart have no conflicts of interest to declare
OSA approval: Zepbound became the first GLP-1 drug approved for obstructive sleep apnea in December 2025
Introduction Dipeptidyl peptidase-4 (DPP-4